Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KD.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XCSORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
XCSORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
XCSECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCSECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCSNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XCSNCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GA.7.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GA.7.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
GA.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.7.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GA.7.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.15.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FL.15.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FL.15.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.15.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.2.40ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BA.2.40ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
BA.2.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.40NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BA.2.40NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
CR.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
CR.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
CR.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
CR.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
KB.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
KB.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
KB.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KB.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KB.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KB.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.3.4ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FL.3.4ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
FL.3.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.3.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.3.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FL.3.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FZ.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
FZ.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-10157.8Germany
FZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FZ.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
FZ.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
DV.7.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used